ArticleHuman vaccines & immunotherapeutics2025

Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease in Canadian infants.

Thomas Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.